Last updated August 29, 2026
Key finding
Intervention effectiveness was significantly associated with positive changes in the underlying mechanisms of behaviour change (R² = 0.26, SE = 0.98, P = 0.00).
This study evaluated the effectiveness of the MAPS intervention on medication adherence in patients with Type 2 Diabetes, showing significant positive changes in adherence-related behaviors.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the effectiveness of the MAPS intervention on medication adherence in patients with Type 2 Diabetes, showing significant positive changes in adherence-related behaviors.
Improving medication adherence is crucial for managing Type 2 Diabetes effectively, as it can lead to better health outcomes and reduce the risk of complications. This study highlights a successful intervention that can be implemented in clinical settings to support patients in their treatment regimens.
Effectiveness of the intervention remains unclear due to unspecified limitations in data interpretation. Potential biases in self-reported adherence behaviors could affect the validity of outcomes. Generalizability may be limited as the study focused on a specific population.
Published in
Publication details and source links for this paper.
Aikaterini K, Charlotte AC, Venus M, James B, Simon E, Stephen S. Post-Trial Process Evaluation of a Digital Intervention to Improve Medication Adherence in Patients with Type 2 Diabetes. Frontiers in Public Health. 2021;9:806168. doi:10.3389/fpubh.2021.806168
Medication adherence behavior improved significantly, with a positive association to behavior change mechanisms.
Motivation to adhere to medication was supported and enhanced by the intervention.
Beliefs about the ability to adhere to medication improved, despite perceived burdens.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Medication Adherence for Patients Support (MAPS) and Improvement in ability to adhere to medication, Improvement in beliefs about ability to adhere to medication, Increased motivation to adhere to medication, and 2 more.
This study contributes evidence to
Primary intervention
Medication Adherence for Patients Support (MAPS)
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
0
Related topics
5
Evidence pairs
0
Related studies
Core evidence
The primary outcomes reported in this study.
Medication Adherence for Patients Support (MAPS) → Improvement in ability to adhere to medication
Medication Adherence for Patients Support (MAPS) → Improvement in ability to adhere to medication
Medication Adherence for Patients Support (MAPS) → Improvement in beliefs about ability to adhere to medication
Medication Adherence for Patients Support (MAPS) → Improvement in beliefs about ability to adhere to medication
Medication Adherence for Patients Support (MAPS) → Increased motivation to adhere to medication
Medication Adherence for Patients Support (MAPS) → Increased motivation to adhere to medication
Medication Adherence for Patients Support (MAPS) → Pain measured using the Von Korff scale
Medication Adherence for Patients Support (MAPS) → Pain measured using the Von Korff scale
Medication Adherence for Patients Support (MAPS) → Self-reported medication adherence at 12 months
Medication Adherence for Patients Support (MAPS) → Self-reported medication adherence at 12 months
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Medication Adherence for Patients Support (MAPS) and Improvement in ability to adhere to medication, Medication Adherence for Patients Support (MAPS) and Improvement in beliefs about ability to adhere to medication.
This study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Behavioral & Lifestyle
Curated evidence collections and hubs this study is part of.
All studies measuring Improvement in ability to adhere to medication
Measures Improvement in ability to adhere to medication as a key outcome.
All studies measuring Improvement in beliefs about ability to adhere to medication
Measures Improvement in beliefs about ability to adhere to medication as a key outcome.
All studies on Medication Adherence for Patients Support (MAPS)
Contributes to Medication Adherence for Patients Support (MAPS) evidence base.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Medication Adherence for Patients Support (MAPS) appears to improve improvement in ability to adhere to medication.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Improvement in ability to adhere to medication
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Medication Adherence for Patients Support (MAPS) appears to improve improvement in beliefs about ability to adhere to medication.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Improvement in beliefs about ability to adhere to medication
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Medication Adherence for Patients Support (MAPS) appears to improve increased motivation to adhere to medication.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Increased motivation to adhere to medication
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Medication Adherence for Patients Support (MAPS) appears to improve self-reported medication adherence at 12 months.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Self-reported medication adherence at 12 months
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
